Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC
Clinical trial NCT03792841 · TERMINATED
Trial details
- NCT number
- NCT03792841
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-05
- Primary completion
- 2023-06-29
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.